Emergent BioSolutions
EBS
#7508
Rank
NZ$0.74 B
Marketcap
NZ$14.36
Share price
2.92%
Change (1 day)
72.62%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2025 (TTM): NZ$2.47

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is NZ$2.39. In 2024 the company made an earnings per share (EPS) of NZ-$6.16 an increase over its 2023 EPS that were of NZ-$25.24.

EPS history for Emergent BioSolutions from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$2.47-140.15%
2024NZ-$6.16-75.61%
2023NZ-$25.24232.21%
2022NZ-$7.60-203.46%
2021NZ$7.34-25.09%
2020NZ$9.80445.28%
2019NZ$1.80-15.2%
2018NZ$2.12-35.9%
2017NZ$3.3169.57%
2016NZ$1.95-27.67%
2015NZ$2.7065.62%
2014NZ$1.6311.63%
2013NZ$1.4632.31%
2012NZ$1.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.31-3.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.40 418.46%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.39 167.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
NZ-$5.49-329.79%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.71-70.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.60-375.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.10-12.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel